The changes of target and organs at risk in patients with high-grade glioma during concurrent chemoradiotherapy were evaluated by MRI image between radiotherapy fractions.
To prospectively evaluate the changes of target organs and risk organs in patients with high-grade glioma during concurrent chemoradiotherapy.The related factors causing this change are discussed.The relationship between changes and patient survival was analyzed.A predictive model was established to provide individualized adaptive radiotherapy for patients.
Study Type
OBSERVATIONAL
Enrollment
60
MRI was performed and adaptive radiotherapy was administered at farction10 and fraction 20 during radiotherapy.
West China Hospital
Chengdu, Sichuan, China
Homogeneity index
HI: Homogeneity index. Dosimetric change
Time frame: up to 2 weeks
conformity index
CI: conformity index. Dosimetric change
Time frame: up to 2 weeks
Anatomic change
Dmax Volume
Time frame: up to 2 weeks
progression-free survival (PFS)
progression-free survival
Time frame: assessed up to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.